Pulse pressure amplification as a hemodynamic predictor of cardiovascular disease

Junichiro Hashimoto

DOI: https://doi.org/10.1038/s41440-024-01880-8

2024-09-11

Hypertension Research

Abstract:Hypertension Research, Published online: 11 September 2024; doi:10.1038/s41440-024-01880-8 Pulse pressure amplification as a hemodynamic predictor of cardiovascular disease

peripheral vascular disease

What problem does this paper attempt to address?

Relationship Between Pulse Pressure and Relative Pulse Wave Velocity in Patients with Essential Hypertension

ZOU Chun-peng,HUANG Pin-tong,YANG Yan,HUANG Fu-guang

DOI: https://doi.org/10.3760/j.issn:1004-4477.2005.04.012

2005-01-01

Abstract:Objective To explore the relationship between pulse pressure and aortic relative pulse wave velocity in the patients with hypertension by Doppler tissue imaging.Methods Velocities of abdominal aortic wall motion were measured in ninety one patients with essential hypertension.Electro mechanical time(EMT),pre ejection period (PEP) and the patient height(H) were measured and recorded respectively,and pulse wave time (PWT) was defined as EMT-PEP and relative pulse wave velocity (RPWV) as H/PWT.Results RPWV in the patients with pulse pressure ≥60 mm Hg ( 1 mm Hg = 0.133 kPa) was significantly greater than that of the patients with pulse pressure60 mm Hg [( 162.03 ± 27.87 )m/s vs ( 75.37 ± 18.74 )m/s,P 0.001 ].Pulse pressure and age were positively related to RPWV (pulse pressure r= 0.536 ,P= 0.000 ;age r= 0.335 ,P= 0.003 ).Conclusions RPWV was closely related to pulse pressure,which may be used in research on hypertension as a new index to evaluate arterial stiffness.
Ambulatory blood pressure monitoring and left ventricular morphology

Takuro Kubozono

DOI: https://doi.org/10.1038/s41440-024-01993-0

2024-11-08

Hypertension Research

Abstract:Hypertension Research, Published online: 07 November 2024; doi:10.1038/s41440-024-01993-0 Ambulatory blood pressure monitoring and left ventricular morphology

peripheral vascular disease
Feasibility of ambulatory blood pressure monitoring to predict cardiovascular outcome in stroke survivors

Ryota Tanaka

DOI: https://doi.org/10.1038/s41440-024-01871-9

2024-09-05

Hypertension Research

Abstract:Hypertension Research, Published online: 04 September 2024; doi:10.1038/s41440-024-01871-9 Feasibility of ambulatory blood pressure monitoring to predict cardiovascular outcome in stroke survivors

peripheral vascular disease
460-P: Pulse Pressure Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Type 2 Diabetes

THOMAS PLATTNER,ALEXANDER VONBANK,ARTHUR MADER,LUKAS SPRENGER,MAXIMILIAN MAECHLER,BARBARA LARCHER,ANDREAS LEIHERER,AXEL MUENDLEIN,HEINZ DREXEL,CHRISTOPH H. SAELY

DOI: https://doi.org/10.2337/db23-460-p

IF: 7.7

2023-06-20

Diabetes

Abstract:Pulse pressure, i.e. the difference between systolic and diastolic blood pressure is a measure of arterial stiffness, which is a strong predictor of cardiovascular risk. Its impact on the risk of cardiovascular events in patients with type 2 diabetes (T2DM) is unclear and is addressed in the present study. We enrolled a large high risk cohort of 1327 patients with established cardiovascular disease (1009 patients with angiographically proven stable CAD and 318 patients with sonographically proven peripheral artery disease). T2DM was diagnosed according to ADA criteria. Prospectively, cardiovascular events were recorded over a mean follow-up period of 9.3±4.6 years. At baseline, pulse pressure was 60±17 mmHg in patients with T2DM (n=481) and 57±17 mmHg in subjects who did not have T2DM (p=0.002). During follow-up, 614 patients suffered cardiovascular events. The event rate was higher in patients with T2DM than in those who did not have diabetes (54.8% vs. 42.2% p<0.001). Pulse pressure significantly predicted cardiovascular events after multivariate adjustment including diabetes status in the total study cohort, with a standardized adjusted hazard ratio (HR) of 1.14 [1.05-1.24]; p=0.003. Importantly, pulse pressure also predicted cardiovascular events in the very high risk subgroup of cardiovascular disease patients with T2DM (HR 1.20 [1.06-1.37]; p=0.006). We conclude that pulse pressure predicts cardiovascular events in cardiovascular disease patients with T2DM. Disclosure T.Plattner: None. C.H.Saely: None. A.Vonbank: None. A.Mader: None. L.Sprenger: None. M.Maechler: None. B.Larcher: None. A.Leiherer: None. A.Muendlein: None. H.Drexel: None.

endocrinology & metabolism
Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Takeshi Fujiwara,Yuichiro Yano,Satoshi Hoshide,Hiroshi Kanegae,Kazuomi Kario

DOI: https://doi.org/10.1001/jamacardio.2018.1233

2018-07-01

JAMA Cardiology

Abstract:Importance: The clinical outcomes associated with masked hypertension defined by home blood pressure monitoring (HBPM) in clinical settings remain uncertain.Objective: To assess the association between masked hypertension and cardiovascular disease events in clinical settings.Design, Setting, and Participants: This observational cohort study used data from 4261 outpatients treated at 71 primary practices or university hospitals throughout Japan who were enrolled in the Japan Morning Surge-Home Blood Pressure study between January 1, 2005, and December 31, 2012. Participants had a history of or risk factors for cardiovascular disease and were followed up through March 31, 2015. Participants underwent clinic blood pressure (BP) measurements on 2 occasions as well as HBPM measurements in the morning and evening for a 14-day period. Urine albumin to creatinine ratio and circulating brain (or B-type) natriuretic peptide levels were quantified at baseline as a marker of cardiovascular end-organ damage. Data were analyzed from July 1, 2017, to October 31, 2017.Exposures: Participants were categorized into 4 BP groups: (1) masked hypertension-hypertensive home BP levels (systolic, ≥135 mm Hg; diastolic, ≥85 mm Hg) and nonhypertensive clinic BP levels (systolic, <140 mm Hg; diastolic, <90 mm Hg); (2) white-coat hypertension-nonhypertensive home BP levels (systolic, <135 mm Hg; diastolic, <85 mm Hg) and hypertensive clinic BP levels (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg); (3) sustained hypertension-hypertensive home and clinic BP levels; and (4) controlled BP-nonhypertensive home and clinic BP levels.Main Outcomes and Measures: Incident stroke and coronary heart disease.Results: Of the 4261 participants, 2266 (53.2%) were women, 3374 (79.2%) were taking antihypertensive medication, and the mean (SD) age was 64.9 (10.9) years. During a median (interquartile range) follow-up of 3.9 (2.4-4.6) years, 74 stroke (4.4 per 1000 person-years) and 77 coronary heart disease (4.6 per 1000 person-years) events occurred. The masked hypertension group had a greater risk for stroke compared with the controlled BP group (hazard ratio, 2.77; 95% CI, 1.20-6.37), independent of traditional cardiovascular risk factors, urine albumin to creatinine ratio, and circulating B-type natriuretic peptide levels. Conversely, masked hypertension yielded no association with coronary heart disease risk.Conclusions and Relevance: In the Japanese general practice population, masked hypertension defined by HBPM may be associated with an increased risk for stroke events. Use of HBPM may improve the assessment of BP-related risks and identify new therapeutic interventions aimed at preventing cardiovascular disease events.

medicine, general & internal
Pulse pressure and kidney outcomes in diabetic kidney disease

Akinori Hara

DOI: https://doi.org/10.1038/s41440-024-01958-3

2024-10-18

Hypertension Research

Abstract:Hypertension Research, Published online: 17 October 2024; doi:10.1038/s41440-024-01958-3 Pulse pressure and kidney outcomes in diabetic kidney disease

peripheral vascular disease
Clinical Significance of Mean and Pulse Pressure in Patients With Heart Failure With Preserved Ejection Fraction

Fang-Fei Wei,Yuzhong Wu,Ruicong Xue,Xiao Liu,Xin He,Bin Dong,Zhe Zhen,Xuwei Chen,Weihao Liang,Jingjing Zhao,Jiangui He,Yugang Dong,Jan A. Staessen,Chen Liu

DOI: https://doi.org/10.1161/hypertensionaha.121.17782

IF: 9.8968

2021-11-06

Hypertension

Abstract:It remains debated whether pulse pressure is associated with left ventricular traits and adverse outcomes over and beyond mean arterial pressure (MAP) in patients with heart failure (HF) with preserved ejection fraction. We investigated these associations in 3428 patients with HF with preserved ejection fraction (51.5% women; mean age, 68.6 years) enrolled in the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist). We computed association sizes and hazards ratios with 1-SD increase in MAP and pulse pressure. In multivariable-adjusted analyses, association sizes ( P ≤0.039) for MAP were 0.016 cm and 0.014 cm for septal and posterior wall thickness, −0.15 for E/A ratio, −0.66 for E/e′, and −0.64% for ejection fraction, independent of pulse pressure. With adjustment additionally applied for MAP, E/A ratio and longitudinal strain increased with higher pulse pressure with association sizes amounting to 0.067 ( P =0.026) and 0.40% ( P =0.023). In multivariable-adjusted analyses of both placebo and spironolactone groups, lower MAP and higher pulse pressure predicted the primary composite end point ( P ≤0.028) and hospitalized HF ( P ≤0.002), whereas MAP was also significantly associated with total mortality ( P ≤0.007). Sensitivity analyses stratified by sex, median age, and region generated confirmatory results with exception for the association of adverse outcomes with pulse pressure in patients with age ≥69 years. In conclusion, the clinical application of MAP and pulse pressure may refine risk estimates in patients with HF with preserved ejection fraction. This finding may help further investigation for the development of HF with preserved ejection fraction preventive strategies targeting pulsatility and blood pressure control.

peripheral vascular disease
Fundamentals of utilizing upstroke time and percentage mean arterial pressure of ankle pulse volume recording as cardiovascular indexes

Yoshiko Watanabe

DOI: https://doi.org/10.1038/s41440-024-01738-z

2024-05-30

Hypertension Research

Abstract:Hypertension Research, Published online: 29 May 2024; doi:10.1038/s41440-024-01738-z Fundamentals of utilizing upstroke time and percentage mean arterial pressure of ankle pulse volume recording as cardiovascular indexes

peripheral vascular disease
Detailed cross-sectional association between traditional risk factors and high systolic blood pressure in a Japanese population

Michihiro Satoh,Takahisa Murakami,Hirohito Metoki

DOI: https://doi.org/10.1038/s41440-024-01639-1

2024-03-12

Hypertension Research

Abstract:Hypertension Research, Published online: 11 March 2024; doi:10.1038/s41440-024-01639-1 Detailed cross-sectional association between traditional risk factors and high systolic blood pressure in a Japanese population

peripheral vascular disease
Examining arterial pulsation to identify and risk-stratify heart failure subjects with deep neural network

Chieh-Chun Huang,Shih-Hsien Sung,Wei-Ting Wang,Yin-Yuan Su,Chi-Jung Huang,Tzu-Yu Chu,Shao-Yuan Chuang,Chern-En Chiang,Chen-Huan Chen,Chen-Ching Lin,Hao-Min Cheng

DOI: https://doi.org/10.1007/s13246-023-01378-6

Abstract:Hemodynamic parameters derived from pulse wave analysis have been shown to predict long-term outcomes in patients with heart failure (HF). Here we aimed to develop a deep-learning based algorithm that incorporates pressure waveforms for the identification and risk stratification of patients with HF. The first study, with a case-control study design to address data imbalance issue, included 431 subjects with HF exhibiting typical symptoms and 1545 control participants with no history of HF (non-HF). Carotid pressure waveforms were obtained from all the participants using applanation tonometry. The HF score, representing the probability of HF, was derived from a one-dimensional deep neural network (DNN) model trained with characteristics of the normalized carotid pressure waveform. In the second study of HF patients, we constructed a Cox regression model with 83 candidate clinical variables along with the HF score to predict the risk of all-cause mortality along with rehospitalization. To identify subjects using the HF score, the sensitivity, specificity, accuracy, F1 score, and area under receiver operating characteristic curve were 0.867, 0.851, 0.874, 0.878, and 0.93, respectively, from the hold-out cross-validation of the DNN, which was better than other machine learning models, including logistic regression, support vector machine, and random forest. With a median follow-up of 5.8 years, the multivariable Cox model using the HF score and other clinical variables outperformed the other HF risk prediction models with concordance index of 0.71, in which only the HF score and five clinical variables were independent significant predictors (p < 0.05), including age, history of percutaneous coronary intervention, concentration of sodium in the emergency room, N-terminal pro-brain natriuretic peptide, and hemoglobin. Our study demonstrated the diagnostic and prognostic utility of arterial waveforms in subjects with HF using a DNN model. Pulse wave contains valuable information that can benefit the clinical care of patients with HF.
Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended

Kazuomi Kario,Naoko Tomitani,Takeshi Fujiwara,Yukie Okawara,Hiroshi Kanegae,Satoshi Hoshide

DOI: https://doi.org/10.1038/s41440-023-01297-9

2023-04-20

Hypertension Research

Abstract:While home blood pressure (BP) measurement is recommended for hypertension management, the clinical implications of peak home BP values have not been well studied. This study investigated the association between pathological threshold or frequency of peak home BP and cardiovascular events in patients with ≥1 cardiovascular risk factor. The Japan Morning Surge-Home Blood Pressure (J-HOP) study enrolled participants from 2005–2012 with extended follow-up from December 2017 to May 2018, which generated the dataset for this analysis. Average peak home systolic BP (SBP) was defined as average of the highest three BP values on 14-day measurement period. Patients were divided into quintiles of peak home BP, and the risk of stroke, coronary artery disease (CAD) and atherosclerotic cardiovascular disease (ASCVD; stroke+CAD) was determined. In 4231 patients (mean 65 years) followed for 6.2 years there were 94 strokes and 124 CAD events. The adjusted hazard ratio (HR) (95% CI) for the risk of stroke and ASCVD in patients with average peak home SBP in the highest versus lowest quintile was 4.39 (1.85–10.43) and 2.04 (1.24–3.36), respectively. Risk was greatest for stroke in the first 5 years: HR 22.66 (2.98–172.1). The pathological threshold of average peak home SBP for 5-year stroke risk was 176 mmHg. There was a linear association between the number of times peak home SBP > 175 mmHg and stroke risk. Peak home BP was a strong risk factor for stroke, especially within the first 5 years. We propose exaggerated peak home SBP > 175 mmHg as an early and strong novel risk factor for stroke.

peripheral vascular disease
Pulse wave-based evaluation of the blood-supply capability of patients with heart failure via machine learning

Sirui Wang,Ryohei Ono,Dandan Wu,Kaoruko Aoki,Hirotoshi Kato,Togo Iwahana,Sho Okada,Yoshio Kobayashi,Hao Liu

DOI: https://doi.org/10.1186/s12938-024-01201-7

2024-01-21

BioMedical Engineering OnLine

Abstract:Pulse wave, as a message carrier in the cardiovascular system (CVS), enables inferring CVS conditions while diagnosing cardiovascular diseases (CVDs). Heart failure (HF) is a major CVD, typically requiring expensive and time-consuming treatments for health monitoring and disease deterioration; it would be an effective and patient-friendly tool to facilitate rapid and precise non-invasive evaluation of the heart's blood-supply capability by means of powerful feature-abstraction capability of machine learning (ML) based on pulse wave, which remains untouched yet. Here we present an ML-based methodology, which is verified to accurately evaluate the blood-supply capability of patients with HF based on clinical data of 237 patients, enabling fast prediction of five representative cardiovascular function parameters comprising left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVDd), left ventricular end-systolic diameter (LVDs), left atrial dimension (LAD), and peripheral oxygen saturation (SpO 2 ). Two ML networks were employed and optimized based on high-quality pulse wave datasets, and they were validated consistently through statistical analysis based on the summary independent-samples t -test ( p > 0.05), the Bland–Altman analysis with clinical measurements, and the error-function analysis. It is proven that evaluation of the SpO 2 , LAD, and LVDd performance can be achieved with the maximum error < 15%. While our findings thus demonstrate the potential of pulse wave-based, non-invasive evaluation of the blood-supply capability of patients with HF, they also set the stage for further refinements in health monitoring and deterioration prevention applications.

engineering, biomedical
Home Blood Pressure Variability Risk Prediction Score for Cardiovascular Disease Using Data From the J-HOP Study

Kazuomi Kario,Hiroshi Kanegae,Yukie Okawara,Naoko Tomitani,Satoshi Hoshide

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.124.23397

IF: 9.8968

Hypertension

Abstract:Background: Home blood pressure (BP) is more closely associated with cardiovascular event risk than office BP, but cardiovascular risk prediction based on home BP variability is lacking. This study developed a simple cardiovascular event prediction score, including home BP variability data, from the J-HOP study (Japan Morning Surge-Home Blood Pressure). Methods: The J-HOP study extended follow-up from December 2017 to May 2018 generated the study data set (4231 patients). Cardiovascular events included fatal/nonfatal stroke (n=94), coronary heart disease (n=124), heart failure (n=42), and aortic dissection (n=8). Cox proportional hazards models were used to predict overall cardiovascular risk. Potential covariates included age, sex, body mass index, smoking, history of diabetes, statin use, history of cardiovascular disease, total cholesterol:high-density lipoprotein cholesterol ratio, office systolic BP (SBP), mean of morning-evening average (MEave), home SBP, and average real variability of MEave home SBP. A risk score and models were constructed, and model performance was assessed. Results: Model performance was best when average real variability of MEave SBP was included (C statistic, 0.760). The risk score assigns points for age (5-year bands), sex, cardiovascular disease history, high-density lipoprotein cholesterol, mean MEave home SBP, and average real variability of MEave home SBP. Estimated 10-year cardiovascular risk ranged from ≤0.6% (score ≤0) to >32% (score ≥26). Calibration 2 statistics values for the model (2.66) and risk score (5.29) indicated excellent goodness of fit. Conclusions: This simple cardiovascular disease prediction algorithm, including day-by-day home BP variability, could be used as part of a home BP-centered approach to hypertension management in clinical practice.
Impact of vascular biomarkers and supine hypertension on cardiovascular outcomes in hypertensive patients: first results from the Cardiovascular Prognostic COUPLING Study in Japan

Kazuomi Kario,Satoshi Hoshide,Tomoyuki Kabutoya,Masafumi Nishizawa,Kayo Yamagiwa,Akihiro Kawashima,Takeshi Fujiwara,Jun Nakazato,Tetsuro Yoshida,Keita Negishi,Yoshio Matsui,Hiromitsu Sekizuka,Yasuhisa Abe,Yumiko Fujita,Toshikazu Hashizume,Tomoko Morimoto,Ryoko Nozue,Hiroshi Kanegae

DOI: https://doi.org/10.1038/s41440-024-01922-1

2024-10-13

Hypertension Research

Abstract:The prognostic impact of vascular biomarkers and supine blood pressure (BP) is not well understood. The multicenter, prospective Coupling study determined the prognostic impact of vascular biomarkers and supine BP in outpatients aged ≥30 years with ≥1 cardiovascular risk factor. Occurrence of major cardiovascular events during follow-up was recorded. The primary outcome was time to onset of a major cardiovascular event. Office and supine BP, the cardio-ankle vascular index (CAVI), and the ankle-brachial index (ABI) were determined annually. Of the 5109 participants in the Coupling study, 4716 were analyzed (51.9% male, mean age 68.5 ± 11.4 years); participants mostly had hypertension treated based on seated office/home BP according to relevant guidelines. During a median follow-up of 5.0 years (interquartile range 3.6–5.2), 231 major cardiovascular events occurred. After adjustment for age, sitting office systolic BP, and other covariates, a 1-unit increase in CAVI (hazard ratio [HR] 1.12, 95% confidence interval [CI] 1.01–1.24) and a 0.1-unit decrease in ABI (HR 1.41, 95% CI 1.18–1.68) were significantly associated with cardiovascular event risk; risk was greatest when CAVI was ≥8.0 and ABI was ≤1.10. Uncontrolled supine hypertension (≥140/90 mmHg) was also significantly associated with adjusted cardiovascular event risk (HR 1.36, 95% CI 1.02–1.81); seated office BP control was not significantly associated with cardiovascular event risk. Increased arterial stiffness, mildly lower ABI, and supine hypertension are risk factors for cardiovascular events during standard clinical practice. Supine evaluation of BP and vascular biomarkers has highlighted a blind spot in current hypertension management (Clinical trial registration: University Hospital Medical Information Network Clinical Trials Registry, UMIN000018474).

peripheral vascular disease
Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice

Kazuomi Kario,Hiroshi Kanegae,Naoko Tomitani,Yukie Okawara,Takeshi Fujiwara,Yuichiro Yano,Satoshi Hoshide,on behalf of the J-HOP Study Group,

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.118.12740

IF: 9.8968

2019-10-07

Hypertension

Abstract:We developed an innovative automated home blood pressure (BP) monitoring method that measures BP while asleep repeatedly over several days. Our aim was to assess the predictive ability of nighttime BP obtained using the home BP device for incident cardiovascular disease (CVD) in general practice patients. We used data from the nationwide practice-based J-HOP (Japan Morning Surge–Home Blood Pressure) Nocturnal BP Study, which recruited 2545 Japanese with a history of or risk factors for CVD (mean age 63 years; antihypertensive medication use 83%). The associations between nighttime home BPs (measured at 2:00, 3:00, and 4:00 am using validated, automatic, and oscillometric home BP devices) and incident CVD, including coronary disease and stroke events, were assessed with Cox proportional hazards models. The mean±SD office, morning home, and nighttime home systolic BP (SBP)/diastolic BP were 140±15/82±10, 137±15/79±10, and 121±15/70±9 mm Hg, respectively. During a follow-up of 7.1±3.8 years (18,116 person-years), 152 CVD events occurred. A 10-mm Hg increase of nighttime home SBP was associated with an increased risk of CVD events (hazard ratios [95% CIs]: 1.201 [1.046–1.378]), after adjustments for covariates including office and morning home SBPs. The model fit assessed by the change in Goodness-of-Fit was improved when we added nighttime home SBP into the base models including office and morning home SBPs (Δ6.838 [5.6%]; P =0.009). This is among the first and largest nationwide practice-based study demonstrating that nighttime SBP obtained using a home device is a predictor of incident CVD events, independent of in-office and morning in-home SBP measurement. URL: http://www.umin.ac.jp/icdr/index.html . Unique identifier: UMIN000000894.

peripheral vascular disease
Pulse pressure and subclinical cardiovascular damage in primary hypertension

Francesca Viazzi,Giovanna Leoncini,Denise Parodi,Maura Ravera,Elena Ratto,Simone Vettoretti,Cinzia Tomolillo,Massimo Del Sette,Gian Paolo Bezante,Giacomo Deferrari,Roberto Pontremoli,F. Viazzi

DOI: https://doi.org/10.1093/ndt/17.10.1779

IF: 7.1857

2002-10-01

Nephrology Dialysis Transplantation

Abstract:BACKGROUND: High pulse pressure (PP) values have recently been implicated in the development and progression of large vessel atherosclerosis, small vessel disease, and in the occurrence of cardiovascular events. The aim of the present study is to investigate the relationship between PP and subclinical cardiovascular damage in a cohort of unselected middle-aged patients (204 male, 129 female) with untreated primary hypertension.METHODS: PP was calculated as the difference between systolic (SBP) and diastolic blood pressure (DBP). Left ventricular mass index (LVMI) was assessed by M-B mode echocardiography (LVH=LVMI>51 g/m(2.7)), and carotid intima-media thickness (IMT) by high-resolution US scan. Albuminuria was measured as the albumin to creatinine ratio (ACR) in three non-consecutive first morning urine samples.RESULTS: PP was positively correlated to gender (P<0.05), duration of disease (P<0.001), age (P<0.0001), LDL cholesterol (P=0.007), and to early signs of target organ damage (TOD), namely LVMI (P<0.0001), IMT (P<0.0001), and ACR (P=0.036). Patients in the upper quartile of PP showed higher LVMI (P<0.001), thicker carotid walls (P<0.001), as well as higher ACR (P<0.04). Multiple linear regression analysis showed that PP and ACR independently influence LVMI (F=26.476, r(2)=0.29, P<0.0001) and IMT (F=17.813, r(2)=0.26, P<0.0001). Patients with LVH, increased carotid IMT and microalbuminuria showed higher PP values as compared with those with lesser degrees of target organ involvement (F=4.97, P<0.003 inter-group comparison). Moreover, the risk of having the simultaneous occurrence of various signs of TOD increases significantly with each SD increase in PP or SBP, but is not influenced by DBP.CONCLUSIONS: PP is an independent marker of preclinical cardiovascular damage in relatively young patients with primary hypertension and, therefore, can be useful for identifying those at higher risk of cardiovascular events.

urology & nephrology,transplantation
COMPARISON OF INFLUENCE OF OFFICE PULSE WAVE VELOCITY AND 24-HOUR AMBULATORY RECORDING OF AORTIC PULSE WAVE VELOCITY ON TARGET DAMAGE IN HYPERTENSION

Huijuam Chao,Qian Wang,Alberto Avolio,Junli Zuo

DOI: https://doi.org/10.1097/01.hjh.0000941744.21606.17

IF: 4.9

2023-06-01

Journal of Hypertension

Abstract:Objective: Arterial stiffness, as measured by pulse wave velocity (PWV), is a significant determinant of target organ damage (TOD). The aim of this study was to assess the potential use of office PWV and 24-hour PWV for prediction of subclinical TOD in a hypertensive cohort. Design and method: We evaluated associations of TOD with office carotid-femoral pulse wave velocity (O-cf-PWV) by radial tonometry (SphygmoCor) and 24-hour ambulatory PWV measurements (24h-PWV, including day-PWV and night-PWV) by brachial oscillometry (Mobil-O-Graph 24h PWA Monitor) in 636 hospital inpatients (age 54 ± 13 years, 465 males) with primary hypertension. Subclinical TOD was defined as left ventricular hypertrophy (LVH) obtained by echocardiography, carotid intima-media thickness (IMT) >0.9mm and chronic kidney disease (CKD) including urine albumin/creatinine ratio (ACR) >3.5 mg/mmol in females and >2.5 mg/mmol in males or estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m 2 . Results: After adjusting for confounding factors, both O-cf-PWV and 24h-PWV or night-PWV showed significant association with LV mass index (p<0.05). Only day-PWV was associated with eGFR (p = 0.039). When O-cf-PWV and 24h-PWV, including other confounding factors, were forced into the same logistic regression model, only O-cf-PWV (OR = 1.117, 95% CI:1.009-1.236, p = 0.033) remained significant determinants of increased LVH. Each 1 m/s increase in 24-h-PWV and day-PWV was associated with decreased risk of eGFR (odds ratio [OR] = 0.340 and 0.43, respectively). Only each increase in night-PWV was associated with risk of carotid IMT > 0.9 mm (OR = 1.360, 95% CI: 1.004 -1.843, p = 0.047). For ACR, neither 24-h-PWV nor O-cf-PWV was significant. Conclusions: O-cf-PWV improved prediction of LVH compared to ambulatory 24h-PWV under ambulatory conditions. Day-PWV may improve prediction of eGFR decline.

peripheral vascular disease
Twenty-Four-Hour Ambulatory Pulse Wave Analysis in Hypertension Management: Current Evidence and Perspectives

Stefano Omboni,Igor N. Posokhov,Yulia V. Kotovskaya,Athanase D. Protogerou,Jacques Blacher

DOI: https://doi.org/10.1007/s11906-016-0681-2

2016-09-22

Current Hypertension Reports

Abstract:The predictive value of vascular biomarkers such as pulse wave velocity (PWV), central arterial pressure (CAP), and augmentation index (AIx), obtained through pulse wave analysis (PWA) in resting conditions, has been documented in a variety of patient groups and populations. This allowed to make appropriate recommendations in clinical practice guidelines of several scientific societies. Due to advances in technologies, largely operator-independent methods are currently available for estimating vascular biomarkers also in ambulatory conditions, over the 24 h. According to the acceptable accuracy and reproducibility of 24-h ambulatory PWA, it appears to be a promising tool for evaluating vascular biomarkers in daily life conditions. This approach may provide an opportunity to further improve the early cardiovascular screening in subjects at risk. However, concerning the clinical use of PWA over the 24 h in ambulatory conditions at the moment, there is no sufficient evidence to support its routine clinical use. In particular, long-term outcome studies are needed to show the predictive value of 24-h PWV, CAP, and AIx values, provided by these devices, over and beyond peripheral blood pressure, and to answer the many technical and clinical questions still open. To this regard, the VASOTENS Registry, an international observational prospective study recently started, will help providing answers on a large sample of hypertensive patients recruited worldwide.

peripheral vascular disease
Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended

Kazuomi Kario,Yukie Okawara,Hiroshi Kanegae,Satoshi Hoshide

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.123.22122

IF: 9.8968

Hypertension

Abstract:Background: The long-term benefit of achieving the Japanese Society of Hypertension home systolic blood pressure (SBP) target of <125 mm Hg has not been fully evaluated. This study investigated the long-term risk of cardiovascular disease events in individuals with home SBP <125 versus 125 to <135 or ≥135 mm Hg who participated in the J-HOP study (Japan Morning Surge-Home Blood Pressure). Methods: The J-HOP study enrolled outpatients with ≥1 cardiovascular risk factor between 2005 and 2012, with follow-up until March 2015 and extended follow-up from December 2017 to May 2018. Cardiovascular disease events (stroke, coronary artery disease, congestive heart failure, and aortic dissection) were compared between home SBP subgroups. Results: During mean 5.9 years of follow-up in 4231 participants (mean age, 65 years), cardiovascular events included stroke (n=89), coronary artery disease (n=116), congestive heart failure (n=37), and aortic dissection (n=8). The adjusted 10-year risk of total cardiovascular disease was slightly higher, and stroke risk was significantly higher when baseline home SBP was ≥135 versus <125 mm Hg (adjusted hazard ratio, 1.39 [95% CI, 0.97-2.00] for overall cardiovascular disease and 2.68 [95% CI, 1.34-5.38] for stroke; this was largely due to between-group differences in the first 5 years of follow-up, which were maintained over the subsequent 5 years). Findings were similar in the subgroup of high-risk patients (those with diabetes or stroke history). Conclusions: These data highlight the potential long-term benefit of strict home SBP control and validate this as an appropriate Japanese Society of Hypertension guideline target although confirmation in larger populations is needed. Registration: URL: https://www.umin.ac.jp/ctr/; University Hospital Medical Information Network Clinical Trials Registry; Unique identifier: UMIN000000894 (Japan Morning Surge-Home Blood Pressure study).
Home Blood Pressure Monitoring: Current Status and New Developments

Kazuomi Kario

DOI: https://doi.org/10.1093/ajh/hpab017

2021-02-09

American Journal of Hypertension

Abstract:Abstract Home blood pressure monitoring (HBPM) is a reliable, convenient, and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM have dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. The accuracy and reliability of home blood pressure (BP) measurements require use of a validated device and standardized procedures, and good patient information and training. Key HBPM parameters include morning BP, evening BP, and the morning–evening difference. In addition, newer semi-automatic HBPM devices can also measure nighttime BP at fixed intervals during sleep. Advances in technology mean that HBPM devices could provide additional relevant data (e.g., environmental conditions) or determine BP in response to a specific trigger (e.g., hypoxia, increased heart rate). The value of HBPM is highlighted by a growing body of evidence showing that home BP is an important predictor of target organ damage, and cardiovascular disease (CVD)- and stroke-related morbidity and mortality, and provides better prognostic information than office BP. In addition, use of HBPM to monitor antihypertensive therapy can help to optimize reductions in BP, improve BP control, and reduce target organ damage and cardiovascular risk. Overall, HBPM should play a central role in the management of patients with hypertension, with the goal of identifying increased risk and predicting the onset of CVD events, allowing proactive interventions to reduce risk and eliminate adverse outcomes.

peripheral vascular disease

Pulse pressure amplification as a hemodynamic predictor of cardiovascular disease

Relationship Between Pulse Pressure and Relative Pulse Wave Velocity in Patients with Essential Hypertension

Ambulatory blood pressure monitoring and left ventricular morphology

Feasibility of ambulatory blood pressure monitoring to predict cardiovascular outcome in stroke survivors

460-P: Pulse Pressure Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Type 2 Diabetes

Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Pulse pressure and kidney outcomes in diabetic kidney disease

Clinical Significance of Mean and Pulse Pressure in Patients With Heart Failure With Preserved Ejection Fraction

Fundamentals of utilizing upstroke time and percentage mean arterial pressure of ankle pulse volume recording as cardiovascular indexes

Detailed cross-sectional association between traditional risk factors and high systolic blood pressure in a Japanese population

Examining arterial pulsation to identify and risk-stratify heart failure subjects with deep neural network

Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended

Pulse wave-based evaluation of the blood-supply capability of patients with heart failure via machine learning

Home Blood Pressure Variability Risk Prediction Score for Cardiovascular Disease Using Data From the J-HOP Study

Impact of vascular biomarkers and supine hypertension on cardiovascular outcomes in hypertensive patients: first results from the Cardiovascular Prognostic COUPLING Study in Japan

Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice

Pulse pressure and subclinical cardiovascular damage in primary hypertension

COMPARISON OF INFLUENCE OF OFFICE PULSE WAVE VELOCITY AND 24-HOUR AMBULATORY RECORDING OF AORTIC PULSE WAVE VELOCITY ON TARGET DAMAGE IN HYPERTENSION

Twenty-Four-Hour Ambulatory Pulse Wave Analysis in Hypertension Management: Current Evidence and Perspectives

Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended

Home Blood Pressure Monitoring: Current Status and New Developments